Q2 FY27 earnings call rescheduled to 4:00 PM IST on October 29, 2026

Board & Shareholder Meetings View source PDF Explain this filing

SENORES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.3%Reaction day

₹1214.00

prior close

₹1219.90

announcement price

After-mkt

timing

Nifty Microcap 250market+0.4%+2.9% vs market

Pharmaceuticals peers, median of 174sector+1.2%+2.1% vs sector

On the reaction day the stock moved 2.9 pts more than Nifty Microcap 250 and 2.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.6

10m

+0.0

15m

+0.9

30m

+1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.3+0.4+2.9+1.2+2.1

Next day

+7.9pendingpending+3.1+4.7

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Senores Pharmaceuticals has moved its Q2 FY27 earnings conference call to 4:00 PM IST on Thursday, October 29, 2026, earlier than the previously announced 5:00 PM time. The call will discuss second-quarter and half-year financial results. A recording and transcript will later be posted on the company website.

Likely market impact

This is a scheduling change, not new financial information. Investors can join one hour earlier to hear management discuss the results, which may affect sentiment.